Search
Ruserontinib
go.drugbank.com/drugs/DB21555InvestigationalRuserontinib is under investigation in clinical trial NCT04716114 (A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated). … The usage of the INN stem '-tinib' in the name indicates that Ruserontinib is a tyrosine kinase inhibitor.
Enbezotinib
go.drugbank.com/drugs/DB21565InvestigationalEnbezotinib is under investigation in clinical trial NCT04161391 (Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations). … The usage of the INN stem '-tinib' in the name indicates that Enbezotinib is a tyrosine kinase inhibitor.
1-benzylimidazole
go.drugbank.com/drugs/DB04581Experimental1-benzylimidazole, an N-imidazole derivative, has been shown to have strong cardiotonic activity.
alpha-D-quinovopyranose
go.drugbank.com/drugs/DB03773ExperimentalThe pyranose form of D-quinovose with an α-configuration at the anomeric position .
T-2000
go.drugbank.com/drugs/DB11654InvestigationalT2000 has been used in trials studying the treatment of Myoclonus and Essential Tremor.
Revamilast
go.drugbank.com/drugs/DB11838InvestigationalRevamilast has been used in trials studying the treatment of Asthma and Rheumatoid Arthritis.
AZD-7687
go.drugbank.com/drugs/DB14949InvestigationalAZD-7687 is under investigation in clinical trial NCT01119352 (AZD7687 Multiple Ascending Dose Study).
ARCT-810
go.drugbank.com/drugs/DB17683InvestigationalARCT-810 is an mRNA replacement therapy that delivers ornithine transcarbamylase mRNA to hepatocytes.
AMT-162
go.drugbank.com/drugs/DB17922InvestigationalAMT-162 is an adeno-associated virus serotype rh10 encoding artificial anti-SOD1 miRNA.
AVID-200
go.drugbank.com/drugs/DB18454InvestigationalAVID-200 is an Anti-transforming growth factor beta (TGF-β) trap fusion protein.